A short synthesis of (−)-prostaglandin E1
✍ Scribed by T Tanaka; T Toru; N Okamura; A Hazato; S Sugiura; K Manabe; S Kurozumi; M Suzuki; T Kawagishi; R Noyori
- Publisher
- Elsevier Science
- Year
- 1983
- Tongue
- French
- Weight
- 157 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0040-4039
No coin nor oath required. For personal study only.
✦ Synopsis
Prostaglandin El has been prepared from (fi)-4-t-butyldimethylsiloxy-2-cyclopentenone by using as a key operation the tandem organocopper conjugate additionlnitroolefin Michael trapping of the resulting enolate intermediate. Regiospecific trapping with electrophiles of enolates generated from 2-cyclenones and lithium diorganocuprates provides a useful tool for the synthesis of 2,3-difunctionalized cyclic ketones. 2 In certain cases, replacement of the organocuprate complexes by organocopper reagents of type RCu[ P(n-C4H9)3]n (p = 2 or 3, empirical formula)3 results in remarkable increase in the efficiency and selectivity of the three-component coupling processes. 495
We found that an enolate which was generated by the reaction of 2-cyclopentenone or its
📜 SIMILAR VOLUMES
Methyl ll-tert-butyldimethylsilyloxyeicosa-8~Z),l2~E),l4(E)trienoate was stereoselectively cyclized by treatment with Hg(OCOCF3j2 to give a properly functionalized PG skeleton, which was converted to PGEl in good over all yield.
An asymmetric total synthesis of Prostaglandin E 1 (5) has with the Corey CBS catalyst gave the ω-side chain 7 with Ͼ96% ee. Conjugate addition using the reaction with been achieved in a two-component coupling process. The chiral hydroxycyclopentenone 6 was readily available from dilithiocyanocuprat
Several groups heve recently reported on their proetaglandln eyntheels (119 (2)9 (3), ( 41, and (5). we would now like to deacrlbe e new route to thle lntereetlng femlly of compounds. Out etarting materiel 1s 2'-carboxy-5-oxo-cyclopent-1-eneheptanolc acid I, ws(CA2)e 03 s cII9W(~2)6 \*.
## Abstract This report describes an efficient stereoselective synthesis of [11β‐^3^H]prostaglandin E~1~ ([11β‐^3^H]PGE~1~). The key multiply protected 11‐keto intermediate was prepared in only three steps from PGE~1~. Reduction of the ketone function at C‐11 with sodium borodeuteride and sodium bo